fungal infections – Page 10

Mycosynthesis of Metal-Containing Nanoparticles—Synthesis by Ascomycetes and Basidiomycetes and Their Application

mycolabadmin

Scientists have discovered that common fungi like mushrooms and molds can produce tiny nanoparticles that fight bacteria, kill cancer cells, and speed up chemical reactions. This fungal method is much cheaper, safer, and more environmentally friendly than traditional chemical production methods. The nanoparticles can be used in medical treatments, wound dressings, water purification, and farming as natural fertilizers and pesticides.

Anticancer drugs targeting topoisomerase II for antifungal treatment

mycolabadmin

Researchers found that several anticancer drugs commonly used to treat human cancers can also effectively kill fungal infections, especially resistant strains of Candida. The most promising drug, idarubicin, works by targeting an essential enzyme in fungi called topoisomerase II, causing DNA damage and cell death. This discovery suggests a new strategy for treating serious fungal infections by repurposing existing cancer medications, particularly for patients with drug-resistant infections.

Regulation and functions of alternative polyadenylation in fungi

mycolabadmin

This review explains how fungi use a process called alternative polyadenylation to create different versions of proteins from the same gene. Think of it like different recipes using the same ingredients but with different instructions. This process is important for fungal survival, growth, and ability to cause disease. Scientists are developing new tools and techniques to study this process, which could lead to better treatments for fungal infections.

Ascosphaera apis as a target for the antifungal activity of symbiotic Bifidobacteria in honey bees

mycolabadmin

Researchers found that certain beneficial bacteria (Bifidobacterium asteroides) living in honey bee guts can fight the fungus that causes chalkbrood disease, a serious condition affecting bee colonies. These bacteria produce natural compounds, especially propanoic acid and ethanol, that kill the fungus and prevent it from growing. This discovery offers a safe, natural alternative to chemical treatments for protecting honeybees from fungal infections while maintaining colony health.

Identification of Filamentous Fungi: An Evaluation of Three MALDI-TOF Mass Spectrometry Systems

mycolabadmin

This study compared three laboratory machines that identify fungi using a technique called MALDI-TOF mass spectrometry. Researchers tested 77 different fungal samples on each machine to see which one worked best. All three machines were useful for routine lab work, but they each worked best at different time points after the fungi started growing. The study shows that labs should be aware of when to test their samples for the most accurate results.

Aspergillus terreus sectorization: a morphological phenomenon shedding light on amphotericin B resistance mechanism

mycolabadmin

When Aspergillus terreus fungi are grown in laboratory conditions for extended periods, they sometimes undergo changes that make them look different and behave differently. Scientists found that these changed strains become more susceptible to amphotericin B, a common antifungal drug. By studying the genes and proteins in both the original and changed strains, researchers discovered that special proteins called P-type ATPases appear to be responsible for the fungus’s natural resistance to this drug, offering new targets for developing better antifungal treatments.

Isolation and molecular identification of pathogens causing sea turtle egg fusariosis in key nesting beaches in Costa Rica

mycolabadmin

Researchers in Costa Rica discovered that a dangerous fungal disease affecting sea turtle eggs is more widespread than previously known. The disease, called sea turtle egg fusariosis, is caused by two types of fungi that can kill developing turtle embryos. Scientists used advanced genetic testing to identify these fungi at major turtle nesting beaches on both coasts of Costa Rica, finding one fungus present at all locations while another was found only on the Caribbean coast. While the disease is not severely harming Costa Rican sea turtles yet, environmental changes could make it worse in the future.

Engineered biosynthesis and characterization of disaccharide-pimaricin

mycolabadmin

Scientists engineered a bacterium to produce a modified antibiotic called disaccharide-pimaricin that fights fungal infections with much better safety. This new compound dissolves better in water (107 times more soluble) and is much less toxic to human blood cells (12.6 times safer) compared to regular pimaricin, while still maintaining antifungal effectiveness. Through optimized fermentation processes, they achieved high production yields of 138 mg/L, making this a promising candidate for safer antifungal treatments.

Global status and trends of invasive pulmonary aspergillosis: A bibliometric study

mycolabadmin

This study analyzes 24 years of research on invasive pulmonary aspergillosis, a serious fungal infection in immunocompromised patients. Using bibliometric tools, researchers mapped out how the field has evolved, identifying leading countries (USA, Germany, China), key experts like David Denning and Thomas Walsh, and shifting research focus from transplant-related infections to COVID-19-associated cases. The analysis shows the field is rapidly growing with increasing emphasis on rapid diagnostic methods and antifungal therapies.

Evaluation of Clinical, Microbiological Profiles and Management Patterns with Outcomes of Patients with Fungal Isolates in An Intensive Care Unit of A Tertiary Care Center: A Prospective Observational Study

mycolabadmin

This study examined fungal infections in patients staying in intensive care units at a hospital. Researchers found that diabetes was the most common risk factor, and a fungus called Candida tropicalis was the most frequently isolated organism from urine samples. Many of the fungal strains were resistant to fluconazole, a common antifungal medication, suggesting doctors need to choose different treatments based on which drugs the fungi are resistant to.

Disease: fungal infections